To confirm the effects of AEP-generated Amphiphysin I fragments in AD pathology, we injected AAVs encoding wild-type Amphiphysin I or N278A mutant Amphiphysin I, which cannot be cleaved by AEP into the hippocampus of two-month-old Tau P301S transgenic mice. This evidence concerns the gene MAPT and Alzheimer disease.